Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Bours

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Biochemical Pharmacology|January 13, 1994
The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell linesV Bours, E Dejardin, F Goujon-Letawe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteinsJ Qian, V Bours, J Manischewitz, et al.
Oncogene|April 7, 1998
Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drugA C Hellin, P Calmant, J Gielen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2000
TNP-470, a potent angiogenesis inhibitor, amplifies human T lymphocyte activation through an induction of nuclear factor-kappaB, nuclear factor-AT, and activation protein-1 transcription factorsR Locigno, N Antoine, V Bours, et al.
Revue Medicale De Liege|May 15, 1987
[Hematologic cancers in 1987. Chemotherapy and immunotherapy]G Fillet, J Bury, Y Beguin, et al.
Oncogene|November 2, 1995
Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cellsE Dejardin, G Bonizzi, A Bellahcène, et al.
Journal of Virology|January 1, 1993
Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutantsP Bressler, K Brown, W Timmer, et al.
Nature|September 24, 1992
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibitionG Franzoso, V Bours, S Park, et al.
European Journal of Biochemistry|December 15, 1996
Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediatesG Bonizzi, E Dejardin, B Piret, et al.
Journal of Drug Targeting|June 14, 2000
Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosisF Princen, C Lechanteur, M Lopez, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|January 13, 1994
The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell linesV Bours, E Dejardin, F Goujon-Letawe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteinsJ Qian, V Bours, J Manischewitz, et al.
Oncogene|April 7, 1998
Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drugA C Hellin, P Calmant, J Gielen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2000
TNP-470, a potent angiogenesis inhibitor, amplifies human T lymphocyte activation through an induction of nuclear factor-kappaB, nuclear factor-AT, and activation protein-1 transcription factorsR Locigno, N Antoine, V Bours, et al.
Revue Medicale De Liege|May 15, 1987
[Hematologic cancers in 1987. Chemotherapy and immunotherapy]G Fillet, J Bury, Y Beguin, et al.
Oncogene|November 2, 1995
Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cellsE Dejardin, G Bonizzi, A Bellahcène, et al.
Journal of Virology|January 1, 1993
Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutantsP Bressler, K Brown, W Timmer, et al.
Nature|September 24, 1992
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibitionG Franzoso, V Bours, S Park, et al.
European Journal of Biochemistry|December 15, 1996
Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediatesG Bonizzi, E Dejardin, B Piret, et al.
Journal of Drug Targeting|June 14, 2000
Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosisF Princen, C Lechanteur, M Lopez, et al.
Pageof 11